EBD Group is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa
07:45 - 17:45 600 mins
Info
Main Agenda
Registration and Exhibition Open

Registration: Entrance

Exhibition: Hall E and Hall C  

07:45 - 10:30 165 mins
Info
Networking
Continental Breakfast

Hall E

08:00 - 17:00 540 mins
Info
Partnering
One-to-one meetings

Hall C

08:00 –17:00  Please note: One-to-one meetings will take place all day depending on your partneri

09:00 - 09:30 30 mins
Info
Workshops
Power up partneringONE: Essentials
  • Speaker Lisa Methley - Senior Director, Online Strategy, EBD Group

Hall C, Room 393

This session is for delegates new to partnering. What you can expect out of partnering, and what others expect from you will form the basis of this workshop. Principles around timing, human nature, and partnering etiquette will be applied to the partneringONE process. Come away from the session with a clear understanding of what you can do to generate the best ROI from partnering, at this and future events.

This session is being offered multiple times during BIO-Europe. Each session is limited to 9 people. Please reserve your seat by adding the session to your personal agenda in your partnering account. Or drop by the Power Zone, by the partnering help desk, with any questions.

09:00 - 12:00 180 mins
Info
Presentations
Company Presentations
10:00 - 11:00 60 mins
Info
Metabolic Track
Is the ecosystem of translational metabolic research in greater Copenhagen sustaining a competitive biotech industry?
  • Moderator Tomas Landh - Innovation Sourcing VP, Senior Principal Scientist, Novo Nordisk
  • Panelist Henrik Blou - CEO, Gubra ApS
  • Panelist Brian Bloomquist - Diabetes External Innovation, Eli Lilly and Company
  • Panelist Jørgen Drejer - CEO, Saniona
  • Panelist Dorte X. Gram - CEO, Pila Pharma
  • Panelist Adam Steensberg - Chief Medical and Development Officer, Executive VP Development, Zealand Pharma A/S

Room B4 

10:00 - 10:30 30 mins
Info
Workshops
Power up partneringONE: Experienced users
  • Speaker Lisa Methley - Senior Director, Online Strategy, EBD Group

Hall C, Room 393 

This session is for delegates familiar with partnering who want to up their game. Best practices for collaborating with colleagues, saving time, increasing response rates and acceptance rates will be discussed in terms of partneringONE, including new power features to support optimal partnering etiquette. Come away from the session with a clear understanding of how partneringONE can support your company to maximize ROI from partnering, at this and future events.

This session is being offered multiple times during BIO-Europe. Each session is limited to 9 people. Please reserve your seat by adding the session to your personal agenda in your partnering account. Or drop by the Power Zone, by the partnering help desk, with any questions.

10:30 - 12:00 90 mins
Info
Additional Program
Harmonization of Health Technology Assessment in Europe
  • Moderator Alexander Natz - Secretary General, European Confederation of Pharmaceutical Entrepreneurs, Belgium
  • Panelist Daniel Reuter - Scientific Advisor, Methods Assessment and Prescribed Services Department, Federal Joint Committee (Healthcare), Germany
  • Panelist Zoe Garrett - Senior Technical Adviser, EUnetHTA, National Institute for Health and Care Excellence, United Kingdom
  • Panelist Bertram Häussler - Chairman, IGES Institute, Germany

Room B5

Health professionals, patients and institutions need to know whether or not a new medicine is an improvement. Health technology assessments (HTA) therefore seek to identify the added value of new medicines, comparing them with other products and existing therapies. In the European Union, HTAs are under the exclusive competence of the European member states. However, cooperation between member states in the field of HTA has existed for more than a decade. On January 31, 2018, the European Commission released a proposal to harmonize the clinical assessment of new drugs. And on October 3, 2018, the European Parliament adopted a new law that aims to boost cooperation between member states in the field of HTA. This panel will discuss the impact of a stronger collaboration on HTA within the EU. It will also provide hands-on information on how innovative biotech companies can benefit from the existing collaboration between the European HTA bodies and how a harmonized European HTA might impact drug development in the near future. 

11:00 - 12:45 105 mins
Info
Metabolic Track
Metabolic Pitch Showcase

Jan Alenfall – CEO, Follicum AB

Henrik Blou – CEO, Gubra ApS

Zachary Gerhart-Hines – Associate Professor, University of Copenhagen; Chief Scientific Officer, Embark Biotech ApS

H. Bjørn Nielsen – Chief Scientific Officer, Clinical Microbiomics

Alexander Hovard Sparre-Ulrich – CEO, Antag Therapeutics

11:05 - 11:25 20 mins
Info
Extra Activity
BREAK AND BREATHE

Upper Level, Room 17

Enhance your conference experience by using simple breathing techniques, movement and light stretches in order to charge your body and mind for better decision making and more energy throughout the day.

Open to all. No prerequisites required. Standing and seated positions only.

11:35 - 11:55 20 mins
Info
Extra Activity
BREAK AND BREATHE

Upper Level, Room 17

Enhance your conference experience by using simple breathing techniques, movement and light stretches in order to charge your body and mind for better decision making and more energy throughout the day.

Open to all. No prerequisites required. Standing and seated positions only.

12:00 - 14:00 120 mins
Info
Networking
Luncheon

Seated Luncheon Hall B 

Grab & Go Lunch Hall E

13:45 - 16:45 180 mins
Info
Additional Program
Side Event/Site Tour: AGC Biologics Facility, Copenhagen

FACILITY TOUR  - CLICK HERE  TO SIGN UP FOR TOUR (DEADLINE: November 2 – limited to 70 participants)                                                                            

AGC Biologics - Copenhagen Facility

Tour Schedule

12:45 pm – Bus pick up at BIO-Europe Bella Center – meeting spot to be communicated

13:30 pm – Welcome and introduction at AGC Biologics Copenhagen, Kasper Møller, Site Head

2:00 pm – Facility Tour

 – Guided site tour in small subgroups through facility visiting labs and cGMP suites

 – Light refreshments and discussion with our Executive Team and Subject Matter Experts

3:45 pm – Bus back to Bella Center (taxis to airport available if needed)


AGC Biologics is a leading global Contract Development and Manufacturing Organization with a strong commitment to deliver the highest standard of service to our clients. We have an extensive network of cGMP facilities in the US, Europe and Asia. We offer deep industry expertise, innovative solutions and customized services for the cGMP manufacture of protein-based therapeutics using mammalian and microbial production systems.

AGC Biologics’ Copenhagen cGMP manufacturing facility operates both microbial and mammalian production lines at a variety of scales. Take the tour to see our facility first hand and understand our capabilities for manufacture of protein therapeutics using microbial and mammalian production systems.

Whatever the challenge, see for yourself why AGC Biologics is your best solution for clinical and commercial manufacturing.

www.agcbio.com 



16:00 - 17:00 60 mins
Info
Networking
CLOSING RECEPTION: Thank you, Copenhagen – Hamburg Ahoy!

Reception to welcome BIO-Europe 2019, November 11-13 in Hamburg, Germany

Hall E, Booth #97